Carisma Therapeutics Inc. (NASDAQ: CARM)
$0.4170
-0.0009 ( -2.11% ) 0.4K
CARISMA Therapeutics Inc is a clinical-stage cell therapy company focused on utilizing Carisma's proprietary chimeric antigen receptor macrophage and monocyte cell engineering platform to develop transformative immunotherapies to treat cancer and other serious diseases. The company has created a comprehensive cell therapy platform to enable the therapeutic use of engineered macrophages and monocytes, which belong to a subgroup of white blood cells called myeloid cells.
Market Data
Open
$0.4170
Previous close
$0.4179
Volume
0.4K
Market cap
$17.45M
Day range
$0.4140 - $0.4550
52 week range
$0.3809 - $3.1600
SEC Filings
Form Type | Description | Pages | Date |
---|---|---|---|
8-k | 8K-related | 13 | Dec 09, 2024 |
10-q | Quarterly Reports | 64 | Nov 07, 2024 |
8-k | 8K-related | 15 | Nov 07, 2024 |
4 | Insider transactions | 1 | Nov 01, 2024 |
3 | Insider transactions | 2 | Nov 01, 2024 |
8-k | 8K-related | 13 | Oct 30, 2024 |
8-k | 8K-related | 13 | Oct 11, 2024 |
8-k | 8K-related | 15 | Aug 08, 2024 |
10-q | Quarterly Reports | 64 | Aug 08, 2024 |
8-k | 8K-related | 17 | Jul 09, 2024 |